Use of persistent free-radicals in magnetic resonance imaging
AssigneeNycomed Imaging AS
InventorsKlaes Golman, Sven Andersson, Frode Rise, Lars-Goran Wistrand, Hakan Wikstrom
Life of this patent
Estimating the term…
Loading patent…
AssigneeNycomed Imaging AS
InventorsKlaes Golman, Sven Andersson, Frode Rise, Lars-Goran Wistrand, Hakan Wikstrom
Estimating the term…
The present invention relates to the use of persistent free radicals, in particular persistent free radicals having a carbon-based .pi.-bonded electronic system available for delocalization of the unpaired electrons as image enhancing agents in magnetic resonance imaging (MRI), in particular electron spin resonance enhanced magnetic resonance imaging (ESREMRI). The invention also relates to contrast media containing such radicals and to the use of such radicals and their non-radical precursors in the manufacture of MRI and ESREMRI contrast media.
An electron spin resonance enhanced nuclear magnetic resonance imaging contrast medium comprising a physiologically tolerable, persistent, water-soluble cyclic .pi.-system free radical, said radical having an inherent linewidth in its esr spectrum of less than 500 mG, said radical having an electron delocalising .pi.-system which comprises at least one homo- or hetero- tricyclic ring, and said radical comprising at least one pair of adjacent ring carbons of a (C.dbd.C).sub.n moiety, where n is a positive integer, or an aryl substituent is substituted to form a fused ring of formula ##STR125## where X.sub.3 is oxygen, sulphur, or SO.sub.2, and Z is C(CH.sub.3).sub.2 or CR.sup.7.sub.2 wherein R.sup.7 is hydrogen or optionally hydroxylated methyl, with a center ring substituted by two oxygen atoms, together with at least one pharmacologically acceptable carrier or excipient.
A method of electron spin resonance enhanced nuclear magnetic resonance investigation of a sample, said method comprising introducing into said sample a persistent, water-soluble cyclic .pi.-system radical, said radical having an inherent linewidth in its esr spectrum of less than 500 mG, said radical having an electron delocalising .pi.-system which comprises at least one homo- or hetero- tricyclic ring, and said radical comprising at least one pair of adjacent ring carbons of a (C.dbd.C).sub.n moiety, where n is a positive integer, or an aryl substituent is substituted to form a fused ring of formula ##STR126## where X.sub.3 is oxygen, sulphur, or SO.sub.2, and Z is C(CH.sub.3).sup.7.sub.2 or CRT.sup.7.sub.2 wherein R.sup.7 is hydrogen or optionally hydroxylated methyl, with a center ring substituted by two oxygen atoms, together with at least one pharmacologically acceptable carrier or excipient,
A non-radical precursor to a physiologically tolerable, persistent, water-soluble cyclic .pi.-system free radical, said radical having an inherent linewidth in its esr spectrum of less than 500 mG, said radical having an electron delocalising .pi.-system which comprises at least one homo- or hetero- tricyclic ring, and said radical comprising at least one pair of adjacent ring carbons of a (C.dbd.C).sub.n moiety, where n is a positive integer, or an aryl substituent is substituted to form a fused ring of formula ##STR127## where X.sub.3 is oxygen sulphur, or SO.sub.2, and Z is C(CH.sub.3).sub.2 or CR.sup.7.sub.2 wherein R.sup.7 is hydrogen or optionally hydroxylated methyl, with a center ring substituted by two oxygen atoms.
A process for preparing a physiologically tolerable, persistent, water-soluble cyclic .pi.-system free radical, said radical having an inherent linewidth in its esr spectrum of less than 500 mG, said radical having an electron delocalising .pi.-system which comprises at least one homo- or hetero- tricyclic ring, and said radical comprising at least one pair of adjacent ring carbons of a (C.dbd.C).sub.n moiety, where n is a positive integer, or an aryl substituent is substituted to form a fused ring of formula ##STR128## where X.sub.3 is oxygen, sulphur, or SO.sub.2, and Z is C(CH.sub.3).sub.2 or CR.sup.7.sub.2 wherein R.sup.7 is hydrogen or optionally hydroxylated methyl, with a center ring substituted by two oxygen atoms,
A persistent, water-soluble cyclic .pi.-system free radical, said radical having an inherent linewidth in its esr spectrum of less than 500 mG, said radical having an electron delocalising .pi.-system which comprises at least one homo- or hetero- tricyclic ring, and said radical comprising at least one pair of adjacent ring carbons of a (C.dbd.C).sub.n moiety, where n is a positive integer, or an aryl substituent is substituted to form a fused ring of formula ##STR129## where X.sub.3 is oxygen, sulphur, or SO.sub.2, and Z is C(CH.sub.3).sub.2 or CR.sup.7.sub.2 wherein R.sup.7 is hydrogen or optionally hydroxylated methyl, with a center ring substituted by two oxygen atoms.
Dependencies are inferred from the claim text.